AJU IB Investment
Seoul, Seoulajuib.co.kr
Overview
AJU IB Investment is South Korea's first venture capital firm, established in 1974. The firm manages alternative investment funds supporting companies throughout their entire lifecycle, from early start-ups to pre/post IPO stages, including VC investments and Buyout & PE investments. It invests in companies operating in the healthcare and technology sectors. The firm is a venture capital and private equity arm of AJU Corporation Co., Ltd. It specializes in mezzanine, buyouts, corporate restructuring, and all stages of venture investments in small to medium sized start-up companies in South Korea.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Illimis Therapeutics | Jul 2025 | Series B | Co-investor |
| Neumous | Jul 2025 | Series A | Co-investor |
| DeepX | May 2024 | Series C | Co-investor |
| Hutom | Feb 2024 | Series C | Co-investor |
| Daan Biotherapeutics | Jan 2024 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.